Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (451-460 of 461) with videos related to

Pageof 47
Sort By:
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2016
Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-projectLuna Gargani, Rosa Sicari, Mauro Raciti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 24, 2025
A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology-Chronic Kidney Disease (SONG-CKD) Stakeholder WorkshopsAndrea Matus Gonzalez, Rosanna Cazzolli, Magdalena Madero, et al.
Eclinicalmedicine|June 23, 2023
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trialStéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
Kidney International|August 21, 2021
A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular riskCarmine Zoccali, Claudia Torino, Francesca Mallamaci, et al.
JAMA|June 4, 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical TrialSunil V Badve, Vlado Perkovic, Vivekanand Jha, et al.
European Heart Journal|July 28, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialJaved Butler, Stefan D Anker, Lars H Lund, et al.
European Journal of Heart Failure|August 30, 2022
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of CardiologyJulio Núñez, Rafael de la Espriella, Patrick Rossignol, et al.
European Journal of Heart Failure|March 25, 2022
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyArantxa González, A Mark Richards, Rudolf A de Boer, et al.
European Journal of Heart Failure|April 30, 2022
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyAlberto Aimo, Giuseppe Vergaro, Arantxa González, et al.
Pageof 47

Showing results (451-460 of 461) with videos related to

Sort By:
Pageof 47
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2016
Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-projectLuna Gargani, Rosa Sicari, Mauro Raciti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 24, 2025
A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology-Chronic Kidney Disease (SONG-CKD) Stakeholder WorkshopsAndrea Matus Gonzalez, Rosanna Cazzolli, Magdalena Madero, et al.
Eclinicalmedicine|June 23, 2023
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trialStéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
Kidney International|August 21, 2021
A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular riskCarmine Zoccali, Claudia Torino, Francesca Mallamaci, et al.
JAMA|June 4, 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical TrialSunil V Badve, Vlado Perkovic, Vivekanand Jha, et al.
European Heart Journal|July 28, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialJaved Butler, Stefan D Anker, Lars H Lund, et al.
European Journal of Heart Failure|August 30, 2022
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of CardiologyJulio Núñez, Rafael de la Espriella, Patrick Rossignol, et al.
European Journal of Heart Failure|March 25, 2022
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyArantxa González, A Mark Richards, Rudolf A de Boer, et al.
European Journal of Heart Failure|April 30, 2022
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyAlberto Aimo, Giuseppe Vergaro, Arantxa González, et al.
Pageof 47